The disappearance of transfusion-transmitted hepatitis C virus infections in the United States

Clinics in Liver Disease

Volumn 5, Issue 4, 2001, Pages 1105-1113

  Gresens, Christopher J ^a,b   Holland, Paul V ^a,b  

^a SMF Blood Centers   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIGEN; VIRUS RNA;

BLOOD DONOR; BLOOD TRANSFUSION; DISEASE TRANSMISSION; HEPATITIS C; HUMAN; INFECTION RISK; NONHUMAN; REVIEW; RISK FACTOR; UNITED STATES;

EID: 0034773060     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70212-9     Document Type: Article

References (42)

1. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: The Transfusion-Transmitted Viruses Study
2. Elimination of both cell-free and cell-associated HIV infectivity in plasma by a filtration/methylene blue photoinactivation system
3. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward
4. Posttransfusion hepatitis in the United States
5. To C or not to C: These are the questions
6. Transmissible agent in non-A, non-B hepatitis
7. Risk factors for acute non-A, non-B hepatitis in the United States and associated hepatitis C virus infection
8. Improved detection of anti-HCV in posttransfusion hepatitis by a third generation ELISA
9. Gift or good? A contemporary examination of the voluntary and commercial aspects of blood donation
10. Psoralen photochemical inactivation of Orientia tsutsugamushi in platelet concentrates
11. Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems
12. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection
13. A case of transmission of hepatitis C virus between sexual partners
14. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
15. Efficacy of HCV core antigen detection during the preseroconversion period
16. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: Comparison of second- and third-generation anti-HCV assays
17. Hepatitis
18. Paid-versus-volunteer blood donation in the United States: A historical review
19. The declining risk of post-transfusion hepatitis C virus infection
20. Transmission of hepatitis C virus by a cardiac surgeon
21. Transfusion-associated hepatitis not due to viral hepatitis type A or B
22. Hepatitis C is focus of NIH consensus panel
23. Risk of viral hepatitis from blood: Status report
24. Posttransfusion hepatitis B
25. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function
26. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
27. Photosensitized inactivation of Plasmoduim falciparum in human red cells by phthalocyanines
28. The use of riboflavin for the viral inactivation of platelets
29. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C outcomes
30. The incidence of post-transfusion hepatitis
31. Infectious disease testing for blood transfusions
32. Sexual transmission of hepatitis C virus
33. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
34. Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors
35. Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients
36. Transfusion-transmitted viral infections
37. The risk of transfusion-transmitted viral infections
38. Clinical tolerance of methylene blue virus-inactivated plasma
39. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: An analysis of the Transfusion-Transmitted Viruses Study
40. NAT of the United States and Canadian blood supply
41. Sensitivity of HIV and HCV RNA detection by pooled genome amplification testing (GAT)